Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

5-Amino-1MQ

Mitochondrial & MetabolicResearch Use Only

Also known as: 5-amino-1-methylquinolinium, NNMT inhibitor

A small molecule (not a true peptide) that blocks an enzyme linked to fat storage and slow metabolism.

Dosing quick reference

research reference
Starting dose
2.5 mg once daily
Frequency
1–2× daily
Typical range
2.5–5 mg per day
Cycle
Typically run 4–8 weeks
Titration (step-up)
Days 1–2: 2.5 mg → Day 3+: 5 mg
Half-life
Not well established in published human data
Route
Oral (research)
Common use
Metabolic enzyme (NNMT) research
Common vial sizes
10 mg · 50 mg
Storage
Store powder in a cool, dry place protected from light; if in solution, keep refrigerated and use within the timeframe supported by stability data.
Stacking notes
Sometimes referenced alongside NAD+ precursors in research discussions on cellular NAD+ metabolism; combinations are not well characterized.

Reported side effects

Limited human safety dataGenerally reported as well tolerated in preclinical studies
Regulatory note: Not approved as a therapeutic drug in Canada or the US; research compound. Research-grade material is not for human use.
Calculate a dose →5-Amino-1MQ on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.